Clinical Trial Update: A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ARRY-371797 in adults undergoing third molar extraction for dental pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Pain

Drugs mentioned

• ARRY-371797

Snippet

Sponsor: Pfizer | Conditions: Dental Pain | Phase 2 | Status: COMPLETED